TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.99
+1.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.35x
- Price / sales
- 0.48x
- Price / cash flow
- -7.63x
Enterprise value
- Enterprise value
- $708.0M
- EV / sales
- 0.61x
- EV / EBITDA
- 43.66x
- EV / EBIT
- -11.83x
- Market cap
- $560.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026